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Abstract 
Understanding phase transitions in pharmaceutical materials is of vital importance for drug 
manufacturing, processing and storage. In this paper we have carried out comprehensive 
high-resolution spectroscopic studies on the polymorphs of the non-steroidal anti-
inflammatory drug diflunisal that has four known polymorphs, forms I – IV (FI – FIV), three 
of which have known crystal structures. Phase transformations during milling, heating, melt-
quenching and exposure to high relative humidity were investigated using Raman and 
terahertz spectroscopy in combination with differential scanning calorimetry and X-ray 
powder diffraction. The observed phase transformations indicate the stability order FIII > FI 
> FII, FIV. Furthermore, crystallization experiments from the gas phase and from solution by 
fast evaporation of different solvents were carried out. Fast evaporation of an ethanolic 
solution below 70 °C was identified as a reliable and convenient method to obtain the 
somewhat elusive FII in bulk quantities.  
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1. Introduction  
The existence of different polymorphic forms of drugs has led to major investment and 
efforts into the discovery and study of polymorphs.(Dharmendra Singhal, 2004; Lee, 2014) During 
drug manufacturing an active pharmaceutical ingredient (API) undergoes various different 
processes and is subjected to different temperatures, pressures and relative humidities. (Yihong 
Qiu, 2009) It is hence vital to understand any polymorphic transformation that a drug substance 
undergoes under different conditions. Understanding crystallization kinetics under various 
conditions will clarify the processes which underpin polymorphic transformations that can 
play an important role in the activity and stability of drugs.  
Traditional solution crystallization experiments can be controlled by adjusting the 
temperature and concentration of the system. (Coquerel, 2014) In a liquid phase, the use of 
higher crystallization temperatures can lead to the most thermodynamically stable 
polymorphic form. (Hao et al., 2012) Sublimation(Kamali, Erxleben, & McArdle, 2016) and melt 
quenching(Patterson JE et al., 2005) are solvent free techniques that can be used for purification 
and for the production of amorphous drug forms, respectively. Furthermore, polymorph seeds 
for bulk crystallization can be obtained by sublimation and melt quenching. It has been 
shown recently that templating can be applied to selectively grow polymorphs by 
sublimation(Kamali et al., 2016),(Srirambhatla, Guo, Price, & Florence, 2016) that otherwise gives the high 
temperature metastable state. (Pallipurath et al., 2015) The fast evaporation technique can provide 
access to kinetically controlled polymorphs. (Bag, Patni, & Reddy, 2011) ROY by Eli Lilly is one 
of the most interesting polymorphic compounds, having nine known forms. The presence of 
these polymorphs were detected on a hot stage microscope, where they crystallized from the 
melt.(Shuang Chen, Ilia A. Guzei, & Yu*, 2005)   
Milling is regularly employed in the pharmaceutical industry for particle size reduction. 
However, it can also lead to polymorphic transformations, often yielding more 
thermodynamically stable forms. (Macfhionnghaile et al., 2014) In contrast, cryogenic milling can 
provide access to metastable and amorphous forms. (Macfhionnghaile et al., 2014) This technique 
has the added advantage that the low temperature used makes the material more brittle and 
thus more millable. Small quantities of solvents added to the milling processes act as 
lubricants or mechanical catalysts for polymorphic transformation. (Friscic, Childs, Rizvi, & Jones, 
2009) Liquid assisted grinding is a subset of solvent assisted milling techniques that are used 
to understand polymorphic transformation and also to screen for co-crystals. (Friscic et al., 2009)  
Diflunisal is a Biopharmaceutics Classification System (BCS) class II, non-steroidal anti-
inflammatory drug used in the treatment of rheumatoid arthritis. It has four known 
polymorphs, all of which crystallize as long, thin needles. Form I (FI) is crystallized from 
toluene (triclinic; unit cell parameters – 3.8, 6.77, 21.65, 82.3, 83.99, 81.98; REF code: 
FAFWIS01). (Cross et al., 2003) Form II (FII) is precipitated from ethanol using water as an 
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anti-solvent.(Brittain, Elder, Isbester, & Salerno, 2005) The single crystal structure could not be 
determined due to the difficulty in growing X-ray suitable single crystals of this polymorph. 
Form III (FIII) is crystallized from ethanol(Cross et al., 2003) and its structure was solved by 
Cross et al. through refinement of its powder pattern (orthorhombic; unit cell parameters – 
39.7, 14.1, 3.83; REF code: FAFWIS02). Form IV (FIV) has a solvate channel structure and 
was reported by Hansen et al. (monoclinic; unit cell parameters – 34.66, 3.74, 20.737, β = 
110.57; REF code: FAFWIS).(Hansen, Perlovich, & Brandl, 2001) The intrinsic dissolution rate 
was reported to follow the order IV>II>III>I, with zero order kinetics, however the order of 
thermodynamic stability amongst the polymorphs has not been clearly established. (Perlovich, 
Hansen, & Bauer-Brandl, 2002) Sung et al. achieved polymorph control through the use of 
different surfactants and microemulsion systems. (Sung, Fan, Yeh, Chen, & Chen, 2013) For 
example, they produced FIII using bicontinous or oil-in-water emulsions and the FIV hydrate 
using water-in-oil emulsion. (Sung et al., 2013) Sung et al. were also able to modify the size and 
aspect ratio of crystals using various surfactants.  
In this paper, we report extensive spectroscopic studies of the phase transformations of 
diflunisal polymorphs. We have also identified a new technique to obtain FII in bulk that is 
superior to the currently used method.  
 
2. Materials and methods 
2.1 Materials  
Diflunisal was purchased from Baoji Guokang Bio-Technology Co.,Ltd, China. The solvents 
were purchased from Sigma Aldrich and were used without further purification.  
2.2 Preparation of polymorphs 
FI is the commercial form and was used as received. FII was obtained by dissolving FI in 
ethanol and precipitating it out with water. (Brittain et al., 2005) FIII was obtained by 
recrystallization of FI from ethanol. (Cross et al., 2003) FIV was obtained by recrystallizing FI 
from a 50:50 mixture of acetone and water.(Hansen et al., 2001) The identity and phase purity of 
all forms was confirmed by X-ray powder diffraction. 
2.3 Ball milling  
Room temperature milling (RTBM) experiments were carried out in an oscillatory ball mill 
(Mixer Mill MM400, Retsch GmbH & Co., Germany) at 25 Hz. using a 25 mL stainless steel 
milling jar containing one 15-mm diameter stainless steel ball. 0.5 g of each sample was 
milled for 5, 15, 30, 60, 90 and 120 mins. For long milling times the jars were allowed to cool 
for 15 min after every 30 mins to avoid overheating.  
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Cryogenic milling (CBM) was carried out using the same set-up. The milling jars were 
initially cooled in liquid nitrogen for 5 min and subsequently for 2.5 min after every 7.5 min 
of milling. Polymorphs FI, FII and FIII were milled for 60 mins and 120 mins.  
Liquid assisted grinding (LAG) experiments were carried out using the same set up, using 
100 µL of nine different solvents, namely: water, acetone, ethanol, methanol, toluene, 
terahydrofuran (THF), dimethyformamide (DMF), valeric acid (VA) and chloroform. These 
systems were milled for 5 min, 10 min and 15 min at room temperature.  
2.4 Fast evaporation   
Diflunisal FI was dissolved in five different solvents: methanol, ethanol, acetone, THF and 
chloroform. The solvents were evaporated at 60 ºC using a rotary evaporator. For higher 
temperatures, up to 130 ºC, fast evaporation was achieved through heating and rapid stirring 
of the solution in a round bottom flask, under reduced pressure in a conventional oil bath 
fitted with a solvent trap.  
2.5 Sublimation  
Sublimation experiments were carried out in a vacuum oven as previously described,6 under 
vacuum (<200 mbar, oven temperature of 80 ºC). The samples were independently heated 
using a microheater fitted to the sublimation area to attain a final temperature of 160 °C. 
Sublimation was carried out for a time interval of 24 hrs for FI and FII, and 10 hrs for FIII.  
2.6 Melt quenching (QM) 
All three polymorphs of diflunisal were melted on a hot plate and subsequently immersed in 
liquid nitrogen and used for further analysis.  
2.7 X-ray powder diffraction (XRPD) 
XRPD patterns of all the samples were collected with an Inel Equinox 3000 (Cu K, 35 kV, 
25 A), between 5 and 80° (2θ) using a curved position sensitive detector calibrated using 
Y2O3. The sample holder was rotated during data collection to reduce preferred orientation 
effects. Calculated patterns for the polymorphs with known crystal structures can be found in 
the Supporting Information (SI, Figure S1).  
2.8 Differential scanning calorimetry (DSC) 
DSC experiments were performed on a STA625 thermal analyser from Rheometric Scientific 
(Piscataway, New Jersey) in open aluminum crucibles, at 10 °C/min, under nitrogen gas. 
Calibration was performed using an indium standard. Further DSC experiments on FII were 
performed on a DSC 8500 (Perkin Elmer) in sealed aluminium pans at 100 °C/min under 
nitrogen gas following temperature and enthalpic calibration with an indium standard.  
2.9 Near infra-red spectroscopy (NIR) 
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NIR spectra of bulk samples (~250 mg) were collected in glass vials (15 mm × 45 mm) on a 
Perkin Elmer Spectrum One fitted with an NIR reflectance attachment. Spectra were 
collected in the range of 10000 − 4000 cm−1, with a resolution of 4 cm−1 and 32 integrated 
scans. 
 
2.10 Attenuated total reflectance infra-red spectroscopy (ATR-IR) 
FT-MIR spectra were collected on a Perkin Elmer Spectrum 400 fitted with an ATR 
reflectance attachment. Spectra were collected in the range of 650 − 3600 cm−1, with a 
resolution of 4 cm−1 and four integrated scans on a diamond/ZnSe window.  
2.11 Terahertz time-domain spectroscopy (THz-TDS) 
The terahertz time domain spectra were collected using the Advantest system (TAS7500TS) 
in the range of 0.2 to 5 THz, at a resolution of 7.6 GHz, and 8192 integrated scans. The 
polymorphs were highly absorbing hence they had to be diluted by geometric mixing of the 
samples with PTFE powder and making pellets using a 2 ton tablet press. The pellets were 
placed in a cuvette under vacuum (2.8 x 10-1 mbar). The temperature was controlled using a 
50 W heater and data were acquired at 10 K intervals from room temperature up to 380 K. 
The absorption spectra were calculated in Matlab following a standard procedure for 
transmission terahertz measurements such as in reference. (Jepsen et al., 2017)  
2.12 Raman spectroscopy  
Raman spectra were collected using the Renishaw Invia micro-Raman spectrometer (100 – 
3600 cm-1 range, 4 cm-1 resolution, 10 s exposure time, 0.5% laser power, 785 nm laser).  
 
3. Results and Discussion  
IR spectral assignments were carried out by Martinez-Oharri et al. (Martinez-Oharriz et al., 1999) 
to unravel the intermolecular hydrogen bonding interactions involved in all four forms of 
diflunisal before the crystal structures were available. Martinez-Oharri et al. concluded that 
FI and IV have similar interactions, while the interactions in FII resemble those in FIII. The 
major difference between FIV and the other forms was found for the (C-F) stretching bands 
between 1310 and 1410 cm-1. We have now carried out an extensive spectroscopic analysis of 
all four forms, taking into account the crystal structure data that are now available.  
Raman spectroscopy (Figure 1) shows clear differences between the four polymorphs in the 
phonon regions, which suggests differences in crystal structure. FI and FIV have out-of-plane 
stretches at 708 cm-1, while FII and III have these stretches at 712 cm-1. All three polymorphs 
have intramolecular H-bonding and the eight membered carboxylic acid dimer motif. (Cross et 
al., 2003) A notable similarity in all four structures is the presence of OH deformations of 
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monomeric COOH groups around 1270 cm-1 suggesting that there are free COOHs on the 
surface of the crystals. The major differences between the four structures are in the carbonyl 
regions, which are influenced by intramolecular H-bonding interactions. Three C=O stretches 
are observed in all polymorphs. Two of the C=O stretches occur at 1611 and 1629 cm-1. 
These stretches are roughly 50 cm-1 lower in wavenumber than typically observed for 
carboxylic acids due to the presence of the ortho-hydroxyl group. (Socrates, 2001) The third 
C=O stretch indicates the extent of intramolecular H-bonding. (Socrates, 2001) FI has this band 
at 1685 cm-1, at higher frequency than the other polymorphs. FIV has the corresponding 
stretch at 1665 cm-1 indicating the next highest degree of H-bonding, followed by FII at 1658 
cm-1 and FIII at 1651cm-1. While in all polymorphs intramolecular H-bonds and the 
carboxylic acid dimer are present, in FI the o-hydroxy groups of adjacent diflunisal molecules 
also form a four-membered ring, which in turn leads to the formation of a chain structure. 
(Cross et al., 2003) This feature is missing in FIII and IV as the o-hydroxy groups on the 
adjacent diflunisal molecules face away from each other (Scheme 1). A more detailed list of 
the spectral differences can be found in Table 1. Brittain et al. carried out fluorescence 
spectroscopy(Brittain et al., 2005) to study the differences in the electronic levels, as a result of 
structural differences of the polymorphs. This they attribute to the extent of interactions due 
to salicylate groups. FI had an emission pattern different from the others, where the double 
excitation bands were separated to a greater extent, which was attributed to the degree of face 
to face interactions of the salicylate group, with FI having no or lesser interactions than the 
other forms, owing to the absence of carboxylic acid dimers. This study was speculative and 
was carried out before the X-ray single crystal structures were determined. It is now evident 
that FI has a greater extent of H-bonding, with the four-membered ortho-OH group H-
bonding motif and the 1D chains apart from the carboxylic acid dimers, which could be the 
reason for the shift in the excitation peaks. 
MIR spectroscopy supports previous findings (Figure S2, SI), where FI is similar to FIV and 
FII is similar to FIII. Out-of-plane CH stretches at 895 cm-1 (1H, Figure 1), out-plane-
deformation at 649 and 670 cm-1 (2H) in 1,2,4-substituted benzene rings and bending modes 
at 1376 cm-1 of COH in OH associated with C=O through H-bonding(Socrates, 2001) are 
present only in FII and III, while they are absent in FI and FIV. While there is ortho F 
disorder in FI and IV, FIII does not have any disordered F atoms. (Cross et al., 2003) The 
stretching and bending modes at 895, 649, 670 and 1376 cm-1 suggest the absence of disorder 
in FII similar to FIII. Clear differences in the out-of-plane deformations of CH and CF can be 
found in the region between 1877 and 1990 cm-1 (Table 2). The major difference in the 
CH…F interactions is that in FI and FIII these interactions are between the rings carrying the 
F atoms, while in the case of FIV they are between the rings carrying the F and the carboxyl-
substituted ring of the adjacent molecule. In a previous study, we showed that the presence of 
a co-former in a diflunisal co-crystal prevents disorder due to the presence of CH…F 
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interactions between the two molecules. (Pallipurath et al., 2016) Structural differences between 
the polymorphs are also reflected in the NIR spectra (Figure S3 and Table S1, SI). There are 
some shifts in the CH-CC combination bands. Red lines in Figure S3 represent peaks that are 
similar in Forms II and III, while green lines are peaks that are similar in FII, III and IV. Blue 
lines are peaks that are similar in FI and IV, with * denoting slight shifts in peaks in FI 
compared to FIV.  
 
3.1 Solution crystallization and fast evaporation techniques  
Diflunisal was crystallized from various solvents by fast removal of the solvent under 
reduced pressure. Acetone, chloroform and THF gave FIV, while methanol gave FIII as 
expected. The corresponding XRPD patterns are shown in the SI (Figure S4). Interestingly, 
ethanol showed temperature dependent results. Figure 2a shows the XRPD patterns at 
intervals of 10 °C, while Figure 2b shows the shifting of the Raman peaks in the carbonyl 
region (1600 – 1700 cm-1) to complement the XRPD data. While at higher temperatures no 
particular polymorph was reliably obtained, at temperatures between 40 and 70 °C FII was 
selectively produced. Usually, FII is prepared by precipitation from ethanol with water and 
tedious filtration of the precipitate in small portions to prevent conversion to FIII during 
filtration. As shown here, fast evaporation of an ethanolic solution of diflunisal below 70 °C 
presents a more convenient and reliable method for the preparation of bulk quantities of this 
polymorph. 
3.2 Heating-induced phase transformations 
3.2.1 Thermal analysis (TA): It is reported that all polymorphs melt at the same temperature, 
except for FIII that has an endotherm at 206 °C. Figure 3a shows the DSC plot of the four 
polymorphs indicating that FI melts at 214.8 °C. FII gives two overlapping endothermic 
events, one peaking at 213 °C and the other at 214 °C, suggesting that FII converts to FI 
before melting. This has not been previously described in the literature. FIII shows a clear 
recrystallization peak at 196 °C and then melts at 214.5 °C, also suggesting a conversion to 
FI. This suggests that FI is the kinetically controlled, high energy phase, in line with the 
literature.14 FIV loses water at 96 °C and then melts at 211 °C. Figure 3b shows the DSC 
thermograms of FII performed at a heating rate of 100 °C/min. On heating (H1) two 
endotherms are observed at 200.5 and 215.5 °C that are assigned to the polymorphic 
transformation of FII to FI followed by the melting of FI, respectively. On cooling from the 
melt (C1) an exothermic crystallization peak is observed at 180 °C. On reheating (H2) only 
one endotherm is observed at 215.5 °C indicating crystallization of FI during cooling.  
3.2.2 Terahertz time-domain spectroscopy: Terahertz time-domain spectroscopy probes 
phonon absorption. To see if the observed transformations are gradual or sudden re-
8 
 
arrangements of atoms, we carried out temperature-dependent terahertz spectroscopy. Figure 
4a shows that FI does not change over the whole temperature range, confirming that it is the 
structure stable at high temperature. In contrast to the DSC analysis, conversion of FIII to FI 
could not be observed on heating up to the maximum accessible temperature (Figure 4b). 
The maximum temperature at which terahertz spectra could be recorded was 480 K (207 °C). 
As this is only slightly above the transition temperature observed by DSC it is likely that poor 
heat transfer between PTFE and diflunisal in the sample pellet is the reason for the failure to 
observe the FIII→FI conversion. Figure 4c shows that FIV very gradually starts converting 
to FI at 440 K (167 °C). Very recently Zhang et al. (Zhang, Wang, Tominaga, & Hayashi, 2016) 
published the mode analysis of FI and FIII, using the chirality of the molecules in the unit cell 
as a basis. This study suggests that both of these polymorphs have similar vibrational 
characteristics below 200 cm-1 and have significant contributions from the coupling of inter- 
and intramolecular modes. Both forms have two molecules in the unit cell and in the case of 
FI, the two molecules are symmetrically equivalent, while in FIII they are not, giving rise to 
non-identical phonon modes. One may note that while the terahertz spectra reported by 
Zhang show very sharp absorption features, it is not so in our case. This is predominantly due 
to the thermal broadening of the spectral peaks as well as the use of PTFE as a diluent. While 
PTFE is not an ideal diluent for terahertz spectroscopy as it may cause scattering effects, it 
has been chosen over other diluents as it allows measurements up to 500 K. Despite these 
effects, the terahertz spectra reported here have sufficient spectral resolution to observe and 
distinguish different polymorphs of diflunisal.  
3.3 Milling induced phase transformations  
3.3.1 Room temperature ball milling: XRPD patterns and Raman spectra of the milling 
experiments are shown in Figures S4 and S5 (SI). On milling for 30 minutes all polymorphs 
converted to FIII. This suggests that FIII is the thermodynamically stable structure. However, 
in the case of FI, FIII converts back to FI, when milling is continued for 120 min. Figure S5a 
shows the Raman spectral changes in the H-bonded C=O stretching region.  
3.3.2 Cryogenic ball milling: Cryomilling of FI, FII and FIII for 60 min resulted in X-ray 
amorphous diflunisal (FA, Figures 5, S6 and S7). The three FA obtained from the different 
polymorphs were then subjected to accelerated temperature and humidity stress testing. 
Separate samples were placed in an oven at 60 °C for 2 hrs, in vacuum for 2 hrs and at 25 and 
95 % relative humidity. Similar tests on other systems have been reported (SHOZO 
MIYAZAKI, 1976). FA produced from all of the polymorphs crystallized to FI (Figures S6 
and S7), suggesting that FI is the easily accessible high energy state, as per Oswald’s rule of 
stages. (Nývlt & Republic, 1995)  
3.3.3 Liquid assisted grinding: LAG experiments were carried out using various solvents. 
Solvents like chloroform, tertrahydrofuran (THF) and valeric acid resulted in FIV solvates 
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(Figure 6). Ethanol, methanol, acetone, toluene and water gave FIII (Figures 6 and S12). 
The formation of FIII on milling in the presence of traces of toluene is noteworthy, as 
solution crystallization from toluene yields FI. Similarly, water and acetone normally yield 
FIV solvate structures, while in the LAG experiments they seem to act as lubricants and lead 
to the thermodynamically stable FIII.  
 
 
 
3.4 Humidity induced transformations 
Another important factor during the processing of drugs is their stability under varying 
humidity conditions. All four polymorphs were placed in 95 % relative humidity chambers. 
FI, FIII and FIV were stable for 24 hrs, while FII converted to FIII as evident from the XRPD 
pattern (Figure S9). This may be explained by the fact that FII and III have very similar 
intermolecular interactions as discussed earlier, making the pathway for transformation easier 
than in the case of other polymorphs.  
3.5 Crystallization from the melt  
Melt quenching is often used as a technique to produce glasses, but in cases of fast 
crystallizers like diflunisal, this often results in the highest energy phase following Ostwald’s 
rule of stages. We have observed that some parts of the melt started crystallizing even before 
it was immersed in liquid nitrogen. The H-bonded carbonyl region in the Raman spectrum of 
melt-quenched FI (Figure S10) suggests that the H-bonding pattern of the crystallized melt is 
very much similar to FI. However, while peaks at 783 and 683 cm-1 in the IR spectrum of 
melt-quenched FI (Figure 7b) are in agreement with this, a shoulder at 848 cm-1 also 
suggests the presence of FIV. The features around 1096 cm-1 suggest the presence of both FI 
and FIV. The XRPD pattern (Figure 7a) indicates the presence of FIV but some FI cannot be 
excluded. Fast crystallization possibly gives rise to FI, while liquid nitrogen may act as a 
solvent in crystallizing the remaining melt into FIV. Another possibility is that FIV is formed 
initially and the liquid nitrogen temperature arrests its conversion to FI.  
3.6 Sublimation 
Sublimation is a technique often used as a recrystallization method to remove impurities. In 
the absence of any template, it invariably results in the high energy metastable phase. 
Sublimation of diflunisal resulted in FI, which is the high temperature metastable state. The 
XRPD pattern is shown in Figure S11. We have previously used polymorph templates to 
control the selective crystallization of carbamazepine polymorphs from the gas phase. (Kamali 
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et al., 2016) Similar templating experiments with diflunisal were unsuccessful and only resulted 
in FI.  
3.7 Order of polymorph stability 
The observed phase transformations give insight into the stability order of the four 
polymorphs of diflunisal. With all forms converting to FI at high temperature, it is safe to say 
that FI is the high temperature metastable form. As all the forms resulted in FIII on milling, 
FIII can be assigned as the thermodynamically stable form. The packing coefficients 
computed for FI and FIII (with disorder removed from FI) of 70.4 and 72.9 % respectively 
also support this stability order. The only technique by which FIV sans solvent molecules in 
its channels can be produced is by melt-quenching, along with FI, suggesting that this form is 
probably formed as the first kinetic product according to Oswald’s rule of stages. The 
presence of solvent in the channels is known to give up to 9 kJ/mol added stability to 
structures, (Cabeza, Day, Motherwell, & Jones, 2007) making the FIV solvate more stable than bare 
FIV. FII is known to convert into FIII on milling and also under humid conditions, making it 
less stable than FIII. However, it also converts partially to FI as seen in the thermal analysis, 
making FII less stable than FI at higher temperatures. The stability order of diflunisal 
polymorphs was first deduced from solubility experiments in water at 30 °C and was found to 
be FII > FIII > FI.(Cotton & Hux, 1985) This was before the existence of either the channel 
solvate FIV(Hansen et al., 2001) or the more recent hydrate(Sung et al., 2013) were known. The 
possibility that conversion to hydrate forms during the original solubility experiments could 
invalidate any stability order conclusions from solubility measurements has been raised. 
(Perlovich et al., 2002) The results reported here in contrast to the solubility based work suggest 
the order FIII > FI > FII, FIV. The relative stability of FII and FIV remains unclear and 
computational studies are currently on-going to establish the order of stability of these 
polymorphs.  
 
4. Conclusions 
In this paper we have carried out extensive spectroscopic and phase transformation studies on 
the non-steroidal anti-inflammatory drug diflunisal. It is often difficult to reliably identify the 
polymorphs formed by XRPD. Spectroscopy can provide a useful alternative. The H-bonding 
patterns of the four polymorphs of diflunisal have a major influence on the carbonyl 
stretching frequencies observed in their Raman spectra. These differences provide a reliable 
basis for the distinction of diflunisal polymorphs. FI and IV, both have disordered F atoms 
and are structurally very similar, resulting in similar Raman and IR patterns. FII and III have 
similar spectral features suggesting that their structures are closely related. The various phase 
transformations undergone by the polymorphs are summarized in Scheme 2.  
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FII, which has a higher intrinsic dissolution rate than FI and III, has generally been very 
elusive, with preparation of bulk quantities hampered by its rapid transformation into FIII. 
Fast evaporation of an ethanolic solution below 80 °C seems to be a reliable method for the 
production of bulk quantities of FII, especially. However, under high relative humidity 
conditions FII eventually converts to FIII.    
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Schemes:  
 
 
 
 
 
 
 
Scheme 1. Interactions in the polymorphs of diflunisal, (a) FI (FAFWIS01), (b) FIII 
(FAFWIS02), and (c) FIV (FAFWIS). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Phase transformations of diflunisal polymorphs under various conditions.  
The dashed arrows indicate that the pathway cannot be unambiguously assigned. 
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Figures 
 
 
 
 
 
 
 
 
 
Figure 1. Molecular structure of diflunisal, with the positions of the carbon atoms in the 1,2,4 
tri-substituted ring denoted as 1H and 2H (left) and different wavenumber ranges of the 
Raman spectra of the four polymorphs (right). The areas highlighted inside blue boxes are the 
peaks that are influenced by the structural differences in the polymorphs, i.e. the nature and 
strength of H-bonding. 
 
 
 
 
 
 
 
 
 
Figure 2. (a) X-ray powder diffraction patterns and (b) Raman spectra of diflunisal 
polymorphs obtained by fast evaporation of ethanol at various temperatures. The inset in (b) 
shows the carbonyl region of the Raman spectra, expanded for clarity. Both techniques show 
the formation of FII between 40 ºC to 70 ºC, and FI or FIII at higher temperatures. 
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Figure 3. Thermal analysis of the polymorphs of diflunisal. (a) Solid lines represent 
differential scanning calorimetry (DSC) and the dotted lines represent thermogravimetric 
analysis (TGA) at 10 ºC/min heating rate. The inset in green shows the recrystallization event 
of FIII to FI. The inset in red shows the double peak in the case of FII. (b) DSC of FII run at 
100 ºC/min (H1), followed by a cooling cycle (C1) and a reheating cycle (H2).  
 
 
 
 
 
 
 
 
 
 
Figure 4. Terahertz time-domain spectroscopic analysis of the polymorphs of diflunisal. (a) 
FI, (b) FIII, and (c) FIV (obtained from acetone and water). FIV converts to FI at 167 °C (440 
K). The colour of the spectra denotes the temperature at which the spectra were obtained. 
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Figure 5. X-ray powder diffraction patterns of (A) FI, (B) FI cryomilled for 60 min and kept 
under vacuum for 2 hrs, (C) FI cryomilled for 60 min and kept at 60 ºC for 2 hrs, (D) FI 
cryomilled for 60 min, (E) FI cryomilled for 60 min and kept at 25% relative humidity and 
(F) FI cryomilled for 60 min and kept at 95% relative humidity. All patterns show ageing and 
formation of FI.  
 
 
 
 
 
 
 
 
 
 
Figure 6. X-ray powder diffraction patterns of diflunisal polymorphs obtained from liquid 
assisted grinding of FI with (a) acetone, methanol, ethanol and water showing the formation 
of FIII and (b) with chloroform, terahydrofuran (THF) and valeric acid showing the 
formation of FIV channel solvates. 
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Figure 7. X-ray powder diffraction patterns of FIV and melt-quenched FI (A), FII (B) and 
FIII (C); (b) Mid-IR spectra of melt-quenched FI, pure FI and FIV showing the presence of 
both FI and FIV in the melt-quenched sample.  
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Table 1. Raman Spectral Assignments of Peaks That Are Distinct in the Four Different 
Polymorphs of Diflunisal 
 
FI FII FIII FIV Assignments 
126 118 (sh) 121 123 
Phonon region 
132 142 137   
181 183 186 181 
204 211 213 204 
234   234 229 
243 238   243 
250 254 254 263 
273 270 275   
        Out-of-plane CH deformation in 
trisubstituted benzenes, 
normally associated with the 
presence of halogen substitution. 
708 712 712 708 
  727 718 725 
        
1230 1221     
CH in-plane deformations  1235   1230 
  1250 1250 1252 
 1275 1271 1273 1273 O-H deformation in COOH 
monomers     1292   
1611 1611 1610 1611 C=O stretching in aromatic 
COOH with ortho-OH 1629 1629 1629 1631 
1685 1658 1651 1665 
C=O stretches involved in intra-
molecular H-bonding 
interactions 
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Table 2. IR Spectral Assignments of the Four Polymorphs of Diflunisal 
 
FI FII FIII FIV Assignments 
  649 649   
Out-of-plane deformation 
(2H) in 1,2,4-trisubstituted 
benzene rings 
  670 670  
698 702 702 700 
714 718 718 716 
728     735 
  894 895   
Out-of-plane deformation 
(1H) in 1,2,4-trisubstituted 
benzene rings.  
1096     1095 C=C stretching in 
asymmetrically substituted 
benzene rings 
  1207 1208  
1298 1329 1329 1297 OH deformations 
  1376 1376   COH bending in OH 
groups associated with 
C=O groups through H-
bonding 
1400 1409 1409 1410 
          
2546 2532 2532 2531 OH stretch in intra-
molecular H-bonded o-
substituted carboxylic acid 
2566 2561 2561  
2603 2623 2618   
2872 2862 2862 2867 
OH stretch in associated 
carboxylic acid 
  2940 2949   
Aromatic C-H stretch   2991 2986  
3075 3052 3063 3077 
  3262 3262   
OH stretch in associated 
carboxylic acid 
1877     1876 
C-H out-of-plane 
deformation, overtones and 
combination bands 
  1908 1905  
   1927  
  1934 1937 1941 
1980  1980 1977 
      1990 
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